查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1750647

全球 DNA 編碼庫市場規模、佔有率和趨勢分析報告：按產品/服務、治療領域、應用、最終用途、地區和細分市場預測 2025-2030 年

DNA-encoded Library Market Size, Share & Trends Analysis Report By Product & Service, By Therapeutic Area, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

DNA編碼庫市場的成長與趨勢：

根據 Grand View Research, Inc. 的最新報告，全球 DNA 編碼庫市場預計到 2030 年將達到 16 億美元，2025 年至 2030 年的複合年成長率為 13.4%。

對新型標靶藥物研發日益成長的需求是推動市場成長的主要因素之一。這些庫能夠對大量化合物進行高通量篩檢，從而大大加快潛在候選藥物的鑑定速度。傳統的化合物篩檢方法可能耗時且耗力，但DNA編碼庫透過將獨特的DNA序列附加到每種化合物上，簡化了這一過程，從而能夠同時快速識別和評估大量候選化合物。這種效率在藥物研發中是一項巨大的優勢，因為速度和準確性至關重要。

推動DNA編碼庫產業發展的另一個關鍵因素是對精準醫療日益成長的關注。隨著醫療保健產業朝著更個人化的治療方向發展，發現特異性針對個人基因譜的藥物的能力變得越來越重要。 DNA編碼庫提供了一種獨特的解決方案，它能夠創建針對特定疾病途徑或患者群體的高度多樣化的庫。這在腫瘤學和遺傳疾病領域尤其有益，因為個人化治療有望改善這些領域的治療效果。

癌症、自體免疫疾病和感染疾病等慢性疾病的盛行率不斷上升，也推動了市場的成長。這些疾病在全球日益加重，這加速了對藥物研發技術的投資，這些技術可以加快有效治療方法的發展。 DNA編碼庫在這一領域發揮關鍵作用，它有助於發現新型小分子、抗體和其他生技藥品，從而有可能滿足尚未滿足的醫療需求。尤其是，人們對抗體和免疫療法日益成長的興趣，凸顯了DNA編碼庫等高效藥物研發方法的重要性。

基因組學和生物資訊學的技術進步進一步推動了市場的成長。定序技術的進步及其成本效益提高了建構大型、高度多樣化DNA編碼庫的能力。生物資訊工具的整合也提高了分析複雜數據的能力，使研究人員能夠最佳化候選化合物的選擇，並提高藥物發現過程的效率。這些進步使得DNA編碼庫更易於取得且更有效率，從而促進了其在製藥和生物技術公司的應用。

此外，製藥公司、學術機構和受託研究機構之間日益增多的合作與夥伴關係也推動了市場擴張。這些合作促進了資源和專業知識的共用，加速了DNA編碼化合物庫技術在藥物研發中的開發和應用。由於突破性藥物的潛力仍然巨大，公共和私人資金的不斷增加也為市場提供了支持。這些因素共同為DNA編碼化合物庫市場的成長和擴張創造了有利環境。

DNA編碼庫市場報告重點

  • 由於藥物發現研究外包的增加，該服務部門預計將引領 DNA 編碼庫產業並在 2024 年產生最高收益。
  • 根據治療領域，腫瘤學領域在 2024 年佔據最大收入佔有率，為 38.32%。
  • 根據應用，由於對高效的先導化合物發現解決方案的需求不斷成長，命中生成/識別部分在 2024 年佔據了 42.52% 的佔有率。
  • 根據最終用途，製藥和生物技術公司在 2024 年佔據最大的收益佔有率，為 42.77%。
  • DNA編碼庫市場由北美主導，這主要歸功於其生物技術部門和強勁的製藥業。

目錄

第1章調查方法與範圍

第2章執行摘要

3. DNA編碼庫市場變數、趨勢與範圍

  • 市場展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • DNA編碼庫市場分析工具
    • 產業分析：波特五力分析
    • PESTEL分析
    • COVID-19影響分析

4. DNA編碼圖書館市場：產品和服務估計和趨勢分析

  • 產品/服務細分儀表板
  • 全球 DNA 編碼庫市場：產品與服務差異分析
  • 2018-2030年全球DNA編碼庫市場規模及趨勢分析（依產品及服務）
  • 產品
    • 產品市場規模、預測及趨勢分析（2018-2030年）
    • 套件和試劑
    • 編碼庫
    • 其他
  • 服務
    • 服務市場規模、預測與趨勢分析（2018-2030年）
    • 設計與合成服務
    • 篩檢服務
    • 其他

第5章 DNA 編碼庫市場：治療領域估計與趨勢分析

  • 治療領域細分儀表板
  • 全球DNA編碼庫市場：依治療領域的變異分析
  • 2018-2030年全球DNA編碼庫市場規模及治療領域趨勢分析
  • 腫瘤學
    • 腫瘤學市場規模、預測與趨勢分析（2018-2030年）
  • 感染疾病
    • 感染疾病市場規模、預測與趨勢分析（2018-2030年）
  • 心血管疾病
    • 心血管疾病市場規模、預測與趨勢分析（2018-2030年）
  • 神經系統疾病
    • 神經系統疾病市場規模、預測與趨勢分析（2018-2030年）
  • 自體免疫疾病
    • 自體免疫疾病市場規模、預測與趨勢分析（2018-2030）
  • 代謝疾病
    • 代謝疾病市場規模、預測與趨勢分析（2018-2030）
  • 其他
    • 其他市場規模、預測和趨勢分析（2018-2030年）

第6章 DNA編碼庫市場：應用評估與趨勢分析

  • 應用程式細分儀表板
  • 全球DNA編碼庫市場：應用變異分析
  • 2018-2030年全球DNA編碼庫市場規模及應用趨勢分析
  • 命中生成/識別
    • 命中生成/識別市場規模、預測和趨勢分析（2018-2030 年）
  • Hit to Lead（H2L）
    • 熱門產品 (H2L) 市場規模、預測與趨勢分析（2018-2030 年）
  • 命中檢驗/最佳化
    • 命中檢驗/最佳化市場規模、預測和趨勢分析（2018-2030）
  • 其他
    • 其他市場規模、預測和趨勢分析（2018-2030年）

7. DNA編碼庫市場：最終用途預估與趨勢分析

  • 最終用途細分儀表板
  • 全球 DNA 編碼庫市場：最終用途變異分析
  • 2018-2030年全球DNA編碼庫市場規模及趨勢分析（依最終用途）
  • 學術研究所
    • 學術研究機構市場規模、預測與趨勢分析（2018-2030 年）
  • 製藥和生物技術公司
    • 製藥和生物技術公司的市場規模、預測和趨勢分析（2018-2030 年）
  • 合約研究組織
    • 合約研究組織市場規模、預測與趨勢分析（2018-2030 年）
  • 其他
    • 其他市場規模、預測和趨勢分析（2018-2030年）

8. DNA編碼庫市場：區域估計與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 參與企業
  • 2024年企業市場分析
  • 戰略地圖
  • 參與企業概況
    • Merck KGaA
    • GenScript
    • Pharmaron
    • WuXi Biology
    • Aurigene Pharmaceutical Services
    • BOC Sciences
    • LGC Bioresearch Technologies
    • SPT Labtech Ltd
    • Life Chemicals
    • Charles River Laboratories
Product Code: GVR-4-68040-564-5

DNA-encoded Library Market Growth & Trends:

The global DNA-encoded library market size is expected to reach USD 1.60 billion by 2030, growing at a CAGR of 13.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising demand for novel and targeted drug discovery is one of the key factors driving the market growth. These libraries enable high-throughput screening of vast chemical compounds, significantly accelerating the identification of potential drug candidates. Traditional methods for screening chemical compounds can be time-consuming and resource-intensive, but DNA-encoded libraries streamline this process by attaching a unique DNA sequence to each compound, making it possible to rapidly identify and evaluate numerous candidates simultaneously. This efficiency is a major advantage in drug discovery, where speed and accuracy are critical.

Another significant factor propelling the growth of the DNA-encoded library industry is the increasing focus on precision medicine. As the healthcare industry moves toward more personalized treatments, the ability to discover drugs that specifically target individual genetic profiles becomes more valuable. DNA-encoded libraries offer a unique solution by enabling the creation of highly diverse libraries that can be tailored to target specific disease pathways or patient populations. This is particularly beneficial in the fields of oncology and genetic disorders, where personalized therapies have shown great promise in improving treatment outcomes.

The rising prevalence of chronic diseases, such as cancer, autoimmune disorders, and infectious diseases, is also contributing to the market growth. The increasing burden of these diseases worldwide has spurred investments in drug discovery technologies that can lead to faster development of effective treatments. DNA-encoded libraries play a critical role in this by facilitating the discovery of novel small molecules, antibodies, and other biologics that can potentially address unmet medical needs. In particular, the growing interest in antibody-based therapies and immunotherapies has highlighted the importance of efficient drug discovery methods like DNA-encoded libraries.

Technological advancements in genomics and bioinformatics have further fueled the market's growth. As sequencing technologies have become more advanced and cost-effective, the ability to construct large, highly diverse DNA-encoded libraries has improved. The integration of bioinformatics tools has also enhanced the ability to analyze complex data, allowing researchers to optimize the selection of candidates and improve the efficiency of the drug discovery process. These advancements have made DNA-encoded libraries more accessible and effective, driving their adoption across pharmaceutical and biotechnology companies.

In addition, the increasing number of collaborations and partnerships between pharmaceutical companies, academic institutions, and contract research organizations is driving market expansion. These collaborations enable the sharing of resources and expertise, accelerating the development and application of DNA-encoded library technology in drug discovery. The market is also supported by increasing funding from both public and private sectors, as the potential for breakthrough drugs remains high. Together, these factors are creating a conducive environment for the growth and expansion of the DNA-encoded library market.

DNA-encoded Library Market Report Highlights:

  • The services segment led the DNA-encoded library industry, generating the highest revenue in 2024, driven by the increasing outsourcing of drug discovery research.
  • Based on therapeutic area, the oncology segment held the largest revenue share of 38.32% in 2024, primarily due to the high demand for targeted cancer therapies.
  • Based on application, the hit generation/identification segment dominated the market in 2024 with a share of 42.52%, due to the growing need for efficient lead discovery solutions.
  • Based on end use, pharmaceutical and biotechnology companies accounted for the largest revenue share of 42.77% in 2024, primarily due to their extensive investment in drug discovery programs.
  • North America is dominant in the market for DNA-encoded libraries, primarily due to its biotechnology sectors and robust pharmaceutical industry.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product & Service
    • 1.2.2. Therapeutic Area
    • 1.2.3. Application
    • 1.2.4. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. DNA-Encoded Library Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing Demand for Drug Discovery & Development
      • 3.2.1.2. Advancements in DNA-Encoded Library Technology & AI Integration
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Complexity in Data Management & Analysis
      • 3.2.2.2. High Initial Investment & Technical Challenges
  • 3.3. DNA-Encoded Library Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. DNA-Encoded Library Market: Product & Service Estimates & Trend Analysis

  • 4.1. Product & Service Segment Dashboard
  • 4.2. Global DNA-Encoded Library Market Product & Service Movement Analysis
  • 4.3. Global DNA-Encoded Library Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
  • 4.4. Products
    • 4.4.1. Products Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.4.2. Kits & Reagents
      • 4.4.2.1. Kits & Reagents Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.4.3. Encoded Libraries
      • 4.4.3.1. Encoded Libraries Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.5.2. Design & Synthesis Services
      • 4.5.2.1. Design & Synthesis Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.5.3. Screening Services
      • 4.5.3.1. Screening Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 5. DNA-Encoded Library Market: Therapeutic Area Estimates & Trend Analysis

  • 5.1. Therapeutic Area Segment Dashboard
  • 5.2. Global DNA-Encoded Library Market Therapeutic Area Movement Analysis
  • 5.3. Global DNA-Encoded Library Market Size & Trend Analysis, by Therapeutic Area, 2018 to 2030 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Oncology Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.5. Infectious Diseases
    • 5.5.1. Infectious Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.6. Cardiovascular Diseases
    • 5.6.1. Cardiovascular Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.7. Neurological Diseases
    • 5.7.1. Neurological Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.8. Autoimmune Diseases
    • 5.8.1. Autoimmune Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.9. Metabolic Diseases
    • 5.9.1. Metabolic Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.10. Other
    • 5.10.1. Other Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 6. DNA-Encoded Library Market: Application Estimates & Trend Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Global DNA-Encoded Library Market Application Movement Analysis
  • 6.3. Global DNA-Encoded Library Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Hit Generation/Identification
    • 6.4.1. Hit Generation/Identification Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD million)
  • 6.5. Hit to Lead
    • 6.5.1. Hit to Lead Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD million)
  • 6.6. Hit Validation/Optimization
    • 6.6.1. Hit Validation/Optimization Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD million)
  • 6.7. Others
    • 6.7.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD million)

Chapter 7. DNA-Encoded Library Market: End Use Estimates & Trend Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Global DNA-Encoded Library Market End Use Movement Analysis
  • 7.3. Global DNA-Encoded Library Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Academic & Research Institutes
    • 7.4.1. Academic & Research Institutes Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 7.5. Pharmaceutical & Biotechnology Companies
    • 7.5.1. Pharmaceutical & Biotechnology Companies Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 7.6. Contract Research Organizations
    • 7.6.1. Contract Research Organizations Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 8. DNA-Encoded Library Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key country dynamics
      • 8.3.1.2. Regulatory framework
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.3.2. Canada
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.3.3. Mexico
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Regulatory framework
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.6. Norway
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. India
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Argentina
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Categorization
  • 9.2. Company Market Position Analysis, 2024
  • 9.3. Strategy Mapping
  • 9.4. Participants Overview
    • 9.4.1. Merck KGaA
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product & service benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. GenScript
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product & service benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Pharmaron
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product & service benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. WuXi Biology
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product & service benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Aurigene Pharmaceutical Services
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product & service benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. BOC Sciences
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product & service benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. LGC Bioresearch Technologies
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product & service benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. SPT Labtech Ltd
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product & service benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Life Chemicals
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product & service benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Charles River Laboratories
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product & service benchmarking
      • 9.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global DNA-Encoded Library Market, by Region, 2018 - 2030 (USD Million)
  • Table 3 Global DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 4 Global DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 5 Global DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 6 Global DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 7 North America DNA-Encoded Library Market, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 9 North America DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 10 North America DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 11 North America DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 12 U.S. DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 13 U.S. DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 14 U.S. DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 15 U.S. DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 16 Canada DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 17 Canada DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 18 Canada DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 19 Canada DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Mexico DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 21 Mexico DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 22 Mexico DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 23 Mexico DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 24 Europe DNA-Encoded Library Market, by Country, 2018 - 2030 (USD Million)
  • Table 25 Europe DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 26 Europe DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 27 Europe DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 28 Europe DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 29 UK DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 30 UK DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 31 UK DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 32 UK DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 33 Germany DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 34 Germany DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 35 Germany DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 36 Germany DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 37 Italy DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 38 Italy DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 39 Italy DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 40 Italy DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 41 France DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 42 France DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 43 France DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 44 France DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Spain DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 46 Spain DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 47 Spain DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 48 Spain DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 49 Sweden DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 50 Sweden DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 51 Sweden DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 52 Sweden DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 53 Denmark DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 54 Denmark DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 55 Denmark DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 56 Denmark DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 57 Norway DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 58 Norway DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 59 Norway DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 60 Norway DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific DNA-Encoded Library Market, by Country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 66 China DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 67 China DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 68 China DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 69 China DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 70 Japan DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 71 Japan DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 72 Japan DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 73 Japan DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 74 India DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 75 India DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 76 India DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 77 India DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 78 South Korea DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 79 South Korea DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 80 South Korea DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 81 South Korea DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 82 Australia DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 83 Australia DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 84 Australia DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 85 Australia DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 86 Thailand DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 87 Thailand DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 88 Thailand DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 89 Thailand DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 90 Latin America DNA-Encoded Library Market, by Country, 2018 - 2030 (USD Million)
  • Table 91 Latin America DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 92 Latin America DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 93 Latin America DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 94 Latin America DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 95 Brazil DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 96 Brazil DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 97 Brazil DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 98 Brazil DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 99 Argentina DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 100 Argentina DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 101 Argentina DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 102 Argentina DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 103 Middle East Africa DNA-Encoded Library Market, by Country, 2018 - 2030 (USD Million)
  • Table 104 Middle East Africa DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 105 Middle East Africa DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 106 Middle East Africa DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 107 Middle East Africa DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 108 South Africa DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 109 South Africa DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 110 South Africa DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 111 South Africa DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 116 UAE DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 117 UAE DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 118 UAE DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 119 UAE DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait DNA-Encoded Library Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 121 Kuwait DNA-Encoded Library Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 122 Kuwait DNA-Encoded Library Market, by Application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait DNA-Encoded Library Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Therapeutic Areas
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value-Chain-Based Sizing & Forecasting
  • Fig. 6 QFD Modeling for Market Share Assessment
  • Fig. 7 Market formulation & Validation
  • Fig. 8 DNA-Encoded Library Market: Market Outlook
  • Fig. 9 Parent Market Outlook
  • Fig. 10 Related/Ancillary Market Outlook
  • Fig. 11 DNA-Encoded Library Market Driver Impact
  • Fig. 12 DNA-Encoded Library Market Restraint Impact
  • Fig. 13 DNA-Encoded Library Market: Product & Service Movement Analysis
  • Fig. 14 DNA-Encoded Library Market: Product & Service Outlook and Key Takeaways
  • Fig. 15 Products Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Kits & Reagents Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Encoded Libraries Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Services Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Design & Synthesis Services Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Screening Services Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 23 DNA-Encoded Library Market: Therapeutic Area Movement Analysis
  • Fig. 24 DNA-Encoded Library Market: Therapeutic Area Outlook and Key Takeaways
  • Fig. 25 Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Infectious Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Cardiovascular Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Neurological Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Autoimmune Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Metabolic Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 DNA-Encoded Library Market: Application Movement Analysis
  • Fig. 33 DNA-Encoded Library Market: Application Outlook and Key Takeaways
  • Fig. 34 Hit Generation / Identification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Hit to Lead Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Hit Validation / Optimization Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 DNA-Encoded Library Market: End Use Movement Analysis
  • Fig. 39 DNA-Encoded Library Market: End Use Outlook and Key Takeaways
  • Fig. 40 Academic & Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Contract Research Organizations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Global DNA-Encoded Library Market: Regional Movement Analysis
  • Fig. 45 Global DNA-Encoded Library Market: Regional Outlook and Key Takeaways
  • Fig. 46 North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 U.S. Country Dynamics
  • Fig. 48 U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Canada Country Dynamics
  • Fig. 50 Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Mexico Country Dynamics
  • Fig. 52 Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 UK Country Dynamics
  • Fig. 55 UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Germany Country Dynamics
  • Fig. 57 Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 France Country Dynamics
  • Fig. 59 France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Italy Country Dynamics
  • Fig. 61 Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Spain Country Dynamics
  • Fig. 63 Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Denmark Country Dynamics
  • Fig. 65 Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Sweden Country Dynamics
  • Fig. 67 Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Norway Country Dynamics
  • Fig. 69 Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 China Country Dynamics
  • Fig. 72 China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Japan Country Dynamics
  • Fig. 74 Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 India Country Dynamics
  • Fig. 76 India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Thailand Country Dynamics
  • Fig. 78 Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 South Korea Country Dynamics
  • Fig. 80 South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Australia Country Dynamics
  • Fig. 82 Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Brazil Country Dynamics
  • Fig. 85 Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Argentina Country Dynamics
  • Fig. 87 Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 South Africa Country Dynamics
  • Fig. 90 South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Saudi Arabia Country Dynamics
  • Fig. 92 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 UAE Country Dynamics
  • Fig. 94 UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Kuwait Country Dynamics
  • Fig. 96 Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Market Position of Key Market Players